Valye reports for unlimited access

Velo3D, Inc. develops and manufactures advanced metal additive manufacturing systems and provides production and engineering services enabling customers to produce high-value metal parts at scale. Its business model combines equipment sales of the Sapphire family of 3D printers and associated software with production services through Rapid Production Solutions (RPS) and Expert Services. The company’s proprietary technology platform integrates print preparation software (Flow), metal 3D printers (Sapphire series), quality assurance software (Assure), and the Intelligent Fusion manufacturing process. Velo3D targets aerospace, defense, energy, automotive, semiconductor, and industrial markets, focusing on customers requiring complex geometries and scalable production. The company operates an asset-light manufacturing model, relying on third-party suppliers for components and final assembly internally. Customers include OEMs and contract manufacturers, with a significant portion of revenue derived from defense-related programs. Velo3D holds a strong intellectual property portfolio and pursues a land-and-expand growth strategy through direct sales and distribution partnerships globally [S1].

Direct Digital Holdings, Inc. is a digital advertising company that provides marketing and advertising services through a technology platform. The company’s operations include a subsidiary, Direct Digital Holdings, LLC, which supports its financial and operational activities. The business faces challenges common to the digital advertising industry, including adapting to changes in tracking technologies and data privacy regulations. Financially, the company has reported significant losses and liquidity constraints as of the end of 2025. The company undertook a reverse stock split in early 2026 to adjust its share structure. Recent operational highlights include recognition for marketing campaigns by its subsidiary Orange 142.

AngioDynamics Inc develops, manufactures, and sells a broad range of medical, surgical, and diagnostic devices primarily for vascular access, peripheral vascular disease treatment, oncology, and surgical applications. Its products are designed for minimally invasive, image-guided procedures and include disposable and temporarily implanted devices. The company operates mainly in the U.S. through a direct sales force and internationally via distributors. Its product portfolio is divided into Med Tech, including platforms like Auryon, thrombus management, and NanoKnife, and Med Device, which includes Core, Venous, Ports, Microwave, and Oncology products. The company focuses on innovation, regulatory pathway expansion, and customer-centric sales to drive growth. It faces macroeconomic challenges such as supply chain issues, inflation, tariffs, and labor shortages, which impact manufacturing and costs.

STARRY SEA ACQUISITION CORP is a Cayman Islands exempted blank check company formed to complete a merger, share exchange, asset acquisition, or similar business combination. It has not generated revenue and focuses on identifying a target business with strong financial visibility, defensible market position, and growth potential. The company completed its IPO in August 2025, raising $57.5 million placed in a trust account. It intends to leverage its management team's expertise and networks to identify and execute a business combination. The company has no operating segments and currently incurs formation and operating costs. It has no long-term debt and maintains liquidity primarily through trust account funds and cash on hand.

CN Healthy Food Tech Group Corp. operates as a holding company with no direct operations, managing its core business through wholly-owned subsidiaries in China. These subsidiaries develop, manufacture, and market premium health foods that integrate AI-powered biotechnology with traditional Chinese medicine principles. The company’s product portfolio includes grain-based health foods and supplements such as Shangshan Suyang Porridge, plant-based essential oils, collagen peptide prebiotics, and gummy supplements. The company relies on OEM suppliers for production and employs a marketing strategy that combines digital and offline channels to attract and retain distributors and customers. The company completed a business combination with Iron Horse Acquisition Corp. in September 2025 and began trading on Nasdaq in October 2025 under ticker UCFI. However, trading has been halted since October 1, 2025, due to the China Securities Regulatory Commission’s ongoing review of the company’s U.S. listing. The company’s financials as of September 30, 2025, show revenue of $7.9 million, net income of $3.3 million, and a strong liquidity position with cash and equivalents of $37.2 million and a current ratio of 1.21. The company faces regulatory uncertainties related to Chinese government approvals for overseas listings and operational risks associated with doing business in China, including compliance with evolving laws and regulations.

KULR Technology Group, Inc. designs and manufactures advanced battery systems targeting autonomous platforms, digital infrastructure, e-mobility, and space applications. The company addresses critical challenges in electrification, focusing on thermal management and safety to enhance system reliability. KULR operates a fully integrated battery design and production facility in Houston, Texas, enabling rapid development and scalable manufacturing of high-performance battery packs. Additionally, KULR develops proprietary vibration reduction technology (KULR VIBE) applicable across various high-speed and rotor-driven systems. In 2025, KULR expanded its business model to include bitcoin treasury management and mining operations, acquiring substantial bitcoin holdings and deploying mining machines under lease agreements. The company generates revenue from product sales, contract services, grant awards, and digital asset mining, with ongoing exploration of licensing opportunities for its technologies.

Infobird Co., Ltd operates primarily in the digital advertising and marketing campaign sector, focusing on the maternal and infant vertical market in Mainland China. The company transitioned away from business integration services by 2025, concentrating its operations on digital marketing. Revenue increased significantly in 2025 following an acquisition in late 2024, with digital advertising services accounting for all reported revenues. The company holds intellectual property rights including patents and software copyrights, which support its technology offerings. Infobird faces high customer concentration risk and foreign exchange exposure due to RMB-denominated operations. The company maintains moderate liquidity with a current ratio near 2.0 as of the end of 2025.

Skillz Inc. is a technology company focused on advancing competitive mobile gaming through its proprietary multi-player platform. The platform enables game developers to integrate real-money tournaments, virtual prizes, and social competition features into their games, supporting player matching, leaderboards, anti-cheat systems, and payment processing. Skillz’s business model centers on monetizing user engagement primarily through prizes, aiming to reduce friction compared to traditional in-game ads or purchases. The company also operates RZR, an AI-driven performance marketing platform that optimizes advertising campaigns across mobile and connected TV channels, integrated with the Skillz platform to enhance user acquisition and monetization. Skillz emphasizes fair play and combats fraudulent bot use in the skill-based gaming industry through legal actions and proprietary technology. The company supports a developer community with a self-serve platform and launched a $75 million Developer Program in 2025 to provide working capital and operational support to select developers. Skillz maintains a loyalty program, automated LiveOps system, and payment infrastructure to enhance player engagement and trust. As of December 31, 2025, Skillz reported a net loss and maintains a cash position supporting ongoing operations.

FG Imperii Acquisition Corp. is a special purpose acquisition company (SPAC) incorporated in the Cayman Islands on September 16, 2025. The company was established to identify and complete a business combination with one or more target businesses, focusing primarily on the financial services sector in North America but without geographic or industry restrictions. The company has not commenced operations and does not generate operating revenues until after completing a business combination. It raised capital through a Proposed Offering of units, with proceeds held in a trust account to be used primarily for the business combination. The company’s management has discretion over the use of funds, subject to Nasdaq rules requiring the business combination to meet certain valuation thresholds. The company’s governance includes a Sponsor and a board of directors, with certain shares and warrants issued to founders and investors. The company is subject to risks typical of early-stage and emerging growth companies, including competition for acquisition targets and operational uncertainties.

Reading International Inc. is a cinema exhibition and real estate company operating in the United States, Australia, and New Zealand. It manages a portfolio of cinemas featuring luxury recliner seating, premium large format auditoriums, and enhanced food and beverage offerings including alcoholic beverages. The company licenses films from major studios and independent distributors, with revenue sharing tied to box office performance. It faces competition from larger cinema chains and streaming platforms, which influence film availability and audience attendance. The real estate segment includes property rental and asset monetizations. Reading is the 14th largest U.S. exhibitor by screen count and holds notable market shares in Australia and New Zealand. The company engages in investor relations through earnings calls and conferences.

TAO Synergies Inc. is a publicly traded company on Nasdaq under the ticker TAOX following a rebrand in mid-2025. The company operates with a complex capital structure including convertible preferred stock and warrants. Financial disclosures indicate the company is in a net loss position with significant accumulated deficit but maintains strong liquidity ratios as of the end of 2025. Revenue sources include TAO staking, though reported revenue amounts are modest relative to expenses. The company has undergone leadership changes in related entities, suggesting strategic adjustments.

Xsolla SPAC 1 is a Cayman Islands-based special purpose acquisition company that completed its IPO on January 30, 2026. The IPO raised $200 million through the issuance of 20 million units, each comprising one Class A ordinary share and one-half of a redeemable warrant. The company also completed a private placement of 400,000 units to its sponsor. The company is listed on Nasdaq under the tickers XSLL (Class A shares), XSLLU (units), and XSLLW (warrants). As a SPAC, its primary business model is to identify and merge with a target company, with proceeds held in trust until such a business combination occurs.

Nuvve Holding Corp. develops and operates a proprietary AI-driven vehicle-to-grid (V2G) technology platform called GIVe, which aggregates electric vehicle (EV) batteries and stationary batteries into virtual power plants (VPPs) to provide bidirectional energy services to the electrical grid. The platform enables EV owners and fleet operators to monetize unused battery capacity by participating in grid services such as frequency regulation, demand response, and energy market participation. Nuvve targets commercial fleet EVs, with a particular focus on the North American school bus market, and operates globally with deployments in Europe, Asia, and North America. The company integrates its technology into V2G-capable charging stations and stationary batteries sourced from manufacturing partners. Nuvve has a history of net losses and reported $4.79 million in revenue and a net loss of $30.8 million for the fiscal year ended 2025. The company faces operational and financial risks including supplier dependency, competition, customer concentration, and capital requirements.

Planet Green Holdings Corp. is a holding company headquartered in Flushing, NY, with operations conducted through subsidiaries in the People's Republic of China and Canada. The company operates in three main segments: consumer products (focused on traditional and modernized dark tea products), chemical products (including methanol fuel additives, alcohol-based fuel, and diesel fuel), and digital advertising services through its subsidiary Fast Approach. The consumer products segment emphasizes quality control through proprietary fermentation and compression techniques, offering products such as brick dark tea, mini brick tea, and loose-leaf tea. The chemical segment operates two production lines with significant annual production capacity. The advertising segment provides digital campaign execution and optimization services in China and North America. Sales are conducted via direct sales, third-party distributors, and sales agents to expand market reach. The company holds multiple patents related to its chemical products. Planet Green is a holding company with no direct operations; its cash flow depends on dividends from subsidiaries, which have not been paid historically. The company faces regulatory risks related to PRC government policies, foreign exchange controls, and cybersecurity regulations. Financially, the company reported revenue of approximately $3 million and a net loss of nearly $27 million for fiscal year 2025, with liquidity ratios indicating current liabilities exceed current assets as of year-end 2025 [S1][S2].

Tailwind 2.0 Acquisition Corp. is a Cayman Islands exempted blank check company established in 2025 to effect a business combination with one or more target businesses. It focuses on companies building the intelligence layer of energy and compute infrastructure, addressing inefficiencies in energy routing, compute optimization, and grid intelligence. The company completed its IPO in November 2025, raising gross proceeds of $172.5 million, which are held in a trust account invested in U.S. government securities until a business combination is consummated. The management team brings extensive operational and capital markets experience, including prior successful IPOs and acquisitions in related sectors. The company targets scalable businesses with strong leadership and defensible competitive positions in high-growth markets such as energy intelligence, compute infrastructure, and digital optimization platforms. It has not yet selected a specific target business and has no operating revenues to date [S1].

Binah Capital Group, Inc. is a platform provider for retail wealth management businesses, owning and operating ten entities including broker-dealers, registered investment advisors, and insurance companies. The company supports over 1,600 registered individuals in the financial services industry. It offers a hybrid business model that allows affiliated advisors to choose between independent, hybrid, and W2 operating models, enabling them to run their practices on their own terms. The platform provides multiple custody and clearing firm options to meet diverse advisor needs. Advisors affiliated with Binah generally operate their own offices and bear most operating expenses, receiving a significant portion of commission-based revenues. The company competes by recruiting advisors, expanding product offerings, pursuing mergers and acquisitions, improving operational efficiencies, and enhancing technology capabilities. Its brokerage subsidiaries provide access to a range of investment products including stocks, bonds, ETFs, insurance, mutual funds, alternative investments, and third-party managed portfolios. The company reported $187.1 million in revenue and $2.3 million in net income for the fiscal year ended December 31, 2025.

Lyra Therapeutics, Inc. operates as a clinical-stage biotechnology company developing localized anti-inflammatory therapies for chronic rhinosinusitis (CRS). Its primary product candidate, LYR-210, is a bioabsorbable nasal implant designed to deliver six months of continuous drug therapy. The company has conducted multiple Phase 3 clinical trials with mixed results, leading to suspension of development and commercialization efforts. Lyra has no approved products or revenue from product sales but has collaboration revenue from a license agreement with LianBio for certain Asian markets. The company has experienced significant workforce reductions and cost-saving measures to preserve capital. It is currently undergoing a strategic review and has been delisted from Nasdaq, with trading suspended. Lyra has incurred substantial net losses and has limited cash resources as of the end of 2025.

Tevogen Bio Holdings Inc. focuses on developing precision T cell therapies leveraging CD8+ cytotoxic T lymphocytes through its ExacTcell technology. This technology produces off-the-shelf, allogeneic T cell therapies targeting specific HLA-restricted antigenic peptides, aiming to treat infectious diseases, cancers, and other disorders with high specificity and reduced adverse effects compared to genetically engineered CAR-T therapies. The lead product candidate, TVGN 489, targets COVID-19 and Long COVID, with completed Phase 1 clinical data supporting safety and cell persistence. The company is preparing pivotal trials and expanding manufacturing capabilities, including potential acquisitions and collaborations. Tevogen also integrates artificial intelligence through its Tevogen.AI initiative to accelerate drug discovery and clinical trial participation. Commercial strategies target large patient populations with unmet needs, including millions affected by Long COVID and various cancers. The company faces typical biotech risks including financing needs, regulatory approvals, manufacturing scale-up, and competitive pressures.

FreeCast, Inc. offers an online platform that aggregates and organizes access to online video, radio, and games through its SmartGuide technology licensed from Nextelligence, Inc. The company has shifted from a single-license to a multi-license revenue model, partnering with various distributors and device manufacturers to generate revenue through free registrations and revenue sharing. As of late 2025, FreeCast reported limited revenue and recurring net losses, with a significant accumulated deficit and liquidity challenges. The business depends on proprietary technology, subscriber acquisition and retention, and maintaining relationships with a small number of key customers. The company operates under a controlled governance structure with concentrated voting power held by its founder and CEO.

FactSet Research Systems Inc. delivers financial intelligence through a global digital platform combining expansive data, analytics, and AI-powered technologies. Its offerings include configurable desktop and mobile platforms, comprehensive data feeds, cloud-based digital solutions, and APIs. The company serves investment professionals across the investment lifecycle, including research, portfolio construction, trade execution, performance measurement, risk management, and reporting. FactSet operates through three geographic segments—Americas, EMEA, and Asia Pacific—and serves client types such as Institutional Buyside, Dealmakers, Wealth, and Market Infrastructure. The CUSIP Global Services business supports critical security master files for the investment industry. Revenues are primarily subscription-based, reflecting recurring services. The company emphasizes embedding AI to enhance client workflows and productivity, with a strategic focus on expanding data offerings and deepening client integration.

Lion Copper & Gold Corp. is a mining exploration company with primary operations in Nevada, USA. It holds a portfolio of copper projects including the historical Yerington mine and other properties. The company is engaged in advancing these projects through exploration, technical studies, and permitting. It has a multi-stage earn-in agreement with Nuton LLC, a Rio Tinto venture, which includes funding for feasibility studies and exploration. The company completed a Pre-Feasibility Study for the Yerington Copper Project in 2025, highlighting the project's economic potential. Lion Copper has secured financing through convertible debentures to support project development and land acquisition. The company is currently dependent on external funding and has not generated operating revenues.

Acuity Inc. is an industrial technology company focused on lighting and intelligent building solutions. It operates two main segments: Acuity Brands Lighting (ABL), which offers sustainable and intelligent lighting products and controls primarily in North America, and Acuity Intelligent Spaces (AIS), which provides building management systems, controls, and audio-video platforms across North America, Europe, and select international markets. The company manufactures products in 18 facilities across the U.S., Mexico, Canada, and Europe, leveraging a mix of internal and outsourced manufacturing. It invests significantly in research and development to enhance product vitality and energy efficiency. Acuity's markets are influenced by economic factors such as construction activity and evolving technologies, and it complies with a range of environmental, privacy, and trade regulations.

Lovesac Co is a U.S.-based furniture retailer that sells primarily modular sectional sofas (Sactionals) and bean bag chairs (Sacs) through a network of company-operated showrooms and an e-commerce website. The company’s omni-channel approach integrates showroom and online sales to provide a seamless customer experience. As of fiscal 2026, Lovesac operated 278 showrooms across the U.S. The company’s revenue mix is predominantly showroom sales, supplemented by internet sales and other channels including pop-up shops and barter transactions, though the latter declined due to strategic changes. Lovesac’s business is seasonal, with higher sales in the holiday quarter. The company’s growth strategy focuses on expanding showroom footprint and renovating existing locations, supported by significant capital expenditures. Lovesac relies on third-party manufacturers primarily located in the U.S. and Asia, and logistics partners for product delivery. The company faces competitive pressures in the retail furniture market and macroeconomic headwinds affecting consumer discretionary spending.

Pharvaris N.V., headquartered in the Netherlands, operates as a late-stage biopharmaceutical company developing therapies for rare diseases with unmet medical needs, initially focusing on angioedema and other bradykinin-mediated diseases. The company’s shares trade on Nasdaq under the ticker PHVS. Pharvaris consolidates several subsidiaries across the Netherlands, the United States, and Switzerland. The company’s financial statements are prepared under IFRS and show significant investment in research and development, reflected in net losses and reclassification of expenses to better align with operational activities. Pharvaris maintains a strong cash position to support ongoing clinical and development activities and has outlined strategic priorities for 2026. The company’s Phase 3 clinical trial for deucrictibant, an on-demand treatment for hereditary angioedema attacks, achieved key endpoints, supporting its clinical pipeline. Pharvaris has attracted notable investment interest and maintains active risk management practices related to currency and liquidity.

LightInTheBox Holding Co., Ltd. operates a global e-commerce platform primarily focused on product sales and logistics services. The company is transitioning from a traditional e-commerce retailer to a brand-focused apparel design business, launching new brands as part of this strategic shift. It serves customers across multiple continents using online marketing and accepts various payment methods. The company manages fulfillment through warehouses and international couriers. Revenues have declined significantly from 2023 to 2025, driven by competitive pressures and strategic focus on margin preservation. The company returned to profitability in 2025 after losses in prior years. Operating expenses include fulfillment, selling and marketing, and general administrative costs, with selling and marketing being the largest expense category. The company invests in technology infrastructure and maintains a portfolio of intellectual property protections. Liquidity remains constrained with net current liabilities as of the end of 2025.

Namib Minerals is a publicly listed mining company incorporated in the Cayman Islands, with its ordinary shares and warrants traded on Nasdaq. The company operates three primary mining segments in Zimbabwe: the Redwing Mine, Mazowe Mine, and How Mine. It reports financials under IFRS, with consolidated statements reflecting revenues, net income, and earnings per share. The company has a classified board structure with independent directors and follows Cayman Islands corporate governance standards. Liquidity ratios as of December 31, 2025, indicate current liabilities exceed current assets, reflecting liquidity challenges. The company has not paid dividends and retains earnings for operational and expansion purposes. The CEO transition in early 2026 is a notable governance event. The company’s primary customer for precious metals is a Zimbabwean governmental entity, which mitigates credit risk on receivables. Public news coverage mainly notes the company’s stock trading activity on Nasdaq.

Algorhythm Holdings, Inc. operates the SemiCab business, an AI-enabled, cloud-based collaborative transportation platform designed to optimize freight logistics by predicting and orchestrating load and truck utilization across networks. The platform integrates with transportation management systems and electronic logging devices to enable shippers, carriers, and third-party logistics providers to reduce empty miles, improve asset utilization, and lower logistics costs. The company offers managed transportation services in India and SaaS-based logistics software subscriptions in the U.S. and Europe. Algorhythm completed the sale of its Singing Machine karaoke consumer products business in August 2025 to focus exclusively on SemiCab. The company has engaged in strategic acquisitions, including SemiCab India, and has secured multiple financing arrangements to support operations and growth.

DynaResource, Inc. operates primarily in the acquisition, development, and production of precious metal properties, with a focus on gold and silver concentrates from its San José de Gracia mine in northern Sinaloa, Mexico. The company has one U.S. subsidiary and four Mexican subsidiaries holding mining concessions. Its product is gold-silver concentrate sold to third parties under market-based pricing arrangements. The company transitioned to a Production Stage issuer in 2025 after establishing mineral reserves. It faces competition from larger mining companies and operates under Mexican mining and environmental regulations. The company reported $58.5 million in revenue and $3.8 million in net income for 2025, with liquidity challenges indicated by a current ratio of 0.24 and zero cash equivalents at year-end. DynaResource employs approximately 241 people and maintains community and environmental programs. It uses commodity hedging to manage price volatility and has outstanding indebtedness of about $15 million. Recent news notes strategic finance and leadership moves to improve stability [N1][S1][S2].

Pharming Group N.V. is an integrated biotechnology company focused on developing and commercializing innovative therapies for rare and ultra-rare diseases, particularly in immunological and genetic disorders. Founded in 1988 and headquartered in the Netherlands, Pharming operates globally with a significant presence in the U.S. The company markets two approved products: RUCONEST®, a recombinant C1 esterase inhibitor for acute hereditary angioedema (HAE), primarily in the U.S., and Joenja® (leniolisib), an oral PI3Kδ inhibitor for activated PI3Kδ syndrome (APDS), approved in multiple countries including the U.S., U.K., Australia, Israel, and Japan. Pharming’s pipeline includes leniolisib for additional primary immunodeficiencies with immune dysregulation and napazimone (KL1333) for primary mitochondrial disease. The company emphasizes patient-centric development, leveraging scientific and commercial expertise to address significant unmet needs in rare diseases. Pharming reported strong revenue growth in 2025, supported by expanding patient identification and market access efforts, and maintains solid financial liquidity to support ongoing operations and pipeline advancement.

Super League Enterprise, Inc. operates at the intersection of the global gaming population and the advertising market by providing brands with audience intelligence and media activation solutions. The company’s platform uses behavioral and psychographic data from gameplay to inform marketing campaigns that reach gamers across multiple digital environments. Its operations are organized into three main areas: Product and Data Platform, Advertising and Marketing Solutions, and Strategic Properties. The Product and Data Platform focuses on scalable, reusable solutions and data insights. Advertising and Marketing Solutions deliver interactive ad formats such as playable ads, rewarded videos, in-game ads, and branded content across gaming platforms and digital channels. Strategic Properties include partnerships and ownership interests in gaming properties that provide advertising inventory and data. The company’s revenue model includes custom interactive programs and increasingly media-based advertising programs designed for scalability and margin improvement. Super League serves brands and agencies primarily in the U.S., leveraging direct sales and agency partnerships. The company faces competition from advertising technology platforms, gaming media platforms, and gaming platform operators, differentiating itself through a platform-agnostic, audience-centric approach. Recent acquisitions aim to expand marketing and measurement capabilities. Financially, the company has reported significant losses but maintains liquidity. Risks include competition, dependence on key customers, evolving market dynamics, and the need for additional capital.

Free Flow USA, Inc. was incorporated in 2011 to engage initially in green energy, focusing on solar pump systems and solar panels for agriculture in India and Pakistan. Early efforts in solar energy and pharmaceutical skin care products did not generate significant revenue. The company later expanded into auto parts recycling through subsidiaries, including Accurate Auto Parts, Inc., but sold these assets in 2024. Currently, Free Flow is active in scrap metal processing and has entered into multiple purchase agreements for scrap metal. The company has also pursued acquisitions and agreements in pharmaceuticals, real estate, steel plant operations in Morocco, and eSports media platforms. The company has a limited number of full-time employees and relies on consultants. It has no owned property or intellectual property as of the latest reports. The CEO, Mr. Sabir Saleem, holds majority control through super voting shares. The company has a history of net losses and limited revenue, with ongoing efforts to develop and expand its business lines. [S1][S2][N1][N2][N3][N4][N5][N6][N7][N8]

TuHURA Biosciences, Inc. is a clinical-stage biopharmaceutical company developing novel therapies primarily for cancer indications. Its lead candidate, IFx-2.0, targets advanced cutaneous melanoma and metastatic Merkel Cell Carcinoma, with FDA Orphan Drug Designation granted for IFx-2.0 in Stage IIB-IV cutaneous melanoma. The company completed a merger with Kineta, Inc. in 2025, adding to its pipeline including KVA12123. TuHURA is advancing clinical trials, including a Phase 3 trial for IFx-2.0, which had a partial FDA hold lifted in mid-2025. The company has no reported revenue and operates at a net loss, with liquidity ratios below 1.0 as of year-end 2025. TuHURA's common stock is listed on Nasdaq but has faced minimum bid price non-compliance notices. The company has engaged in recent equity offerings to raise capital for operations and development.

Cloudastructure, Inc. provides AI-powered cloud-native security solutions that deliver real-time situational awareness to enterprises, focusing on protecting people, property, and brand reputation. Its offerings include cloud video surveillance with AI/ML analytics, remote guarding software, live remote guarding services, and operational intelligence dashboards. The company primarily serves multifamily residential and property management markets, with expansion into commercial real estate, construction, critical infrastructure, transportation, and logistics. Cloudastructure’s platform integrates AI-driven monitoring with human oversight, enabling proactive crime deterrence and operational efficiency. The business model is subscription-based, charging monthly fees per camera, supported by financing options to facilitate customer upgrades. The company reported $5.07 million in revenue and a net loss of $8.46 million for the fiscal year ended December 31, 2025, with strong liquidity metrics. It faces risks including customer concentration, competition, technology development, regulatory compliance, and ongoing operating losses [S1][S2].

Aureus Greenway Holdings Inc is a holding company incorporated in Nevada that operates two public golf country clubs in Florida: Kissimmee Bay Country Club and Remington Golf Club. These clubs feature 18-hole golf courses with extensive recreational amenities including aquatic driving ranges, pro shops, and food and beverage services. The company’s business model centers on providing affordable, approachable golf experiences to local residents and tourists in the greater Orlando area. Revenue streams are diversified across green fees, memberships, retail sales, rentals, food and beverage, and event hosting. The company’s operations are seasonal, with peak activity in the winter and early spring months. Recent capital improvements and renovations aim to enhance course quality and customer experience. Marketing efforts leverage digital advertising and partnerships with tee-time platforms to attract golfers. The company competes locally with several other golf clubs and resorts in the Orlando region [S1].

Charlie's Holdings, Inc. is a company engaged in the development, marketing, and sale of nicotine, synthetic nicotine, and alternative vapor products. The company does not have internal manufacturing capacity and relies on third-party contract manufacturers for production. It operates in a highly regulated environment, subject to extensive federal, state, and local laws, including FDA regulations requiring premarket tobacco applications (PMTAs) for its products. The company has submitted PMTAs for certain products and is currently involved in legal proceedings related to FDA Marketing Denial Orders. Charlie's Holdings faces intense competition from larger tobacco and vapor product companies and operates in a niche, evolving market with uncertain demand. The company has recently raised capital through a private stock offering and has sold certain product assets to R.J. Reynolds Vapor Company.

Golden Growers Cooperative is a value-added agricultural cooperative association owned by 1,445 members primarily from Minnesota, North Dakota, and South Dakota. The Cooperative was formed in 1994 to enable members to gain additional value from their corn through processing into products such as corn sweeteners. The Cooperative owns a 50% interest in ProGold LLC, which owns a corn wet-milling facility in Wahpeton, North Dakota. ProGold leases the facility to Cargill, which operates it and processes corn delivered by Cooperative members. The Cooperative's members are contractually obligated to deliver approximately 15.5 million bushels of corn annually to the facility. The Cooperative's income derives primarily from its share of lease payments made by Cargill to ProGold. The Cooperative operates under Minnesota cooperative law and is treated as a partnership for tax purposes. In late 2024, the Cooperative and Cargill announced that a long-term joint venture agreement would not be possible, leading to a Plan of Liquidation and Dissolution approved by members in 2025, including the sale of the Cooperative's ProGold interest to Cargill by the end of 2026.